Certain Common Stock of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2023.
Details:
Directors, officers and certain of stockholders have agreed with the underwriter, subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of common stock or securities convertible into or exercisable or exchangeable for common stock for a period of six months with respect to our directors, officers and certain of stockholders after the date of this prospectus.